相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Harnessing the power of memory-like NK cells to fight cancer
Yun Yan Foo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)
NK cell therapy in relapsed refractory multiple myeloma
Elham Roshandel et al.
CLINICAL IMMUNOLOGY (2023)
NK cell defects: implication in acute myeloid leukemia
Selma Z. D'Silva et al.
FRONTIERS IN IMMUNOLOGY (2023)
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
Jordi Pfeifer Serrahima et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Combination of cytokines and PM21-particle stimulation results in robust expansion of memory-like Natural Killer cells with enhanced survival
Jeremiah L. Oyer et al.
CANCER RESEARCH (2023)
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
Jeffrey J. Bednarski et al.
BLOOD (2022)
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
Melissa M. Berrien-Elliott et al.
BLOOD (2022)
Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia
Thunyamon Chajuwan et al.
LEUKEMIA & LYMPHOMA (2022)
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
Melissa M. Berrien-Elliott et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
Adrien Krug et al.
CANCERS (2022)
Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis
Guanfang Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Memory NK cells to forget relapsed AML
Robin Parihar
BLOOD (2022)
Transcriptional and Epigenetic Regulation of Gasdermins
Emilie Bourdonnay et al.
JOURNAL OF MOLECULAR BIOLOGY (2022)
Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2022)
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Nina Lamers-Kok et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Doehner et al.
BLOOD (2022)
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
Dhanashree Murugan et al.
CANCERS (2022)
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia
Han Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri et al.
FRONTIERS IN IMMUNOLOGY (2022)
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe
Luciano Castiello et al.
CANCERS (2022)
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting
Yongfeng Chen et al.
CELL DEATH DISCOVERY (2022)
Allogeneic natural killer cell therapy
Melissa M Berrien-Elliott et al.
BLOOD (2022)
Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+Lymphoma
Yago Nieto et al.
BLOOD (2022)
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
Ryan J. Stubbins et al.
CURRENT ONCOLOGY (2022)
Expansion, persistence, and efficacy of donor memory- like NK cells infused for posttransplant relapse
Roman M. Shapiro et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells
Linda Quatrini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity
Hind Rafei et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies
Michael Dickinson et al.
BLOOD (2021)
Acute myeloid leukemia: current progress and future directions
Hagop Kantarjian et al.
BLOOD CANCER JOURNAL (2021)
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Mubin Tarannum et al.
STEM CELL RESEARCH & THERAPY (2021)
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
Lucila N. Kerbauy et al.
CLINICAL CANCER RESEARCH (2021)
Current Perspectives on Off-The-Shelf Allogeneic NK and CAR-NK Cell Therapies
Erica L. Heipertz et al.
FRONTIERS IN IMMUNOLOGY (2021)
DEVELOPMENT OF WU-NK-101, A FEEDER CELL-FREE EXPANDED ALLOGENEIC MEMORY NK CELL PRODUCT WITH POTENT ANTI-TUMOR ACTIVITY
Ryan Sullivan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Emerging agents and regimens for AML
Hongtao Liu
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
Francesco Paolo Tambaro et al.
LEUKEMIA (2021)
Cytokine-induced natural killer cell training is dependent on cellular metabolism and is defective in obesity
Nidhi Kedia-Mehta et al.
BLOOD ADVANCES (2021)
NK cell memory: discovery of a mystery
Ulrich H. von Andrian
NATURE IMMUNOLOGY (2021)
Metabolic changes of Interleukin-12/15/18-stimulated human NK cells
Inigo Terren et al.
SCIENTIFIC REPORTS (2021)
Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches
Matteo Tanzi et al.
CANCERS (2021)
Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
Kwang-Soo Kim et al.
PHARMACEUTICS (2021)
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
Idoia Mikelez-Alonso et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy
Michelle K. Becker-Hapak et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
Natasha Mupeta Kaweme et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
Irina Buckle et al.
CANCERS (2021)
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Synat Kang et al.
CURRENT ONCOLOGY (2021)
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
Jana Rakova et al.
ONCOIMMUNOLOGY (2021)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges
Nicholas J. Short et al.
CANCER DISCOVERY (2020)
Immune escape and immunotherapy of acute myeloid leukemia
Luca Vago et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
NK Cell-Mediated Recall Responses: Memory-Like, Adaptive, or Antigen-Specific?
Victoria Stary et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Treatment of Relapsed Acute Myeloid Leukemia
Felicitas Thol et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
Margery Gang et al.
BLOOD (2020)
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au et al.
SCIENCE ADVANCES (2020)
Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies
Massimo Giuliani et al.
CELLS (2020)
Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations
Patricia J. Ahl et al.
COMMUNICATIONS BIOLOGY (2020)
Research Progress on NK Cell Receptors and Their Signaling Pathways
Yingying Chen et al.
MEDIATORS OF INFLAMMATION (2020)
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies
Tobias Bald et al.
NATURE IMMUNOLOGY (2020)
Modulating NK cell metabolism for cancer immunotherapy
Inigo Terren et al.
SEMINARS IN HEMATOLOGY (2020)
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia
Melissa M. Berrien-Elliott et al.
CANCER DISCOVERY (2020)
A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses
Victoria Stary et al.
SCIENCE IMMUNOLOGY (2020)
Natural killer cell-based immunotherapy for acute myeloid leukemia
Jing Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Michele Stanchina et al.
CANCERS (2020)
Dynamic Changes of Inhibitory Killer-Immunoglobulin-Like Receptors on NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation: An Initial Study
Tereza Dekojova et al.
JOURNAL OF CLINICAL MEDICINE (2020)
New directions for emerging therapies in acute myeloid leukemia: the next chapter
Naval Daver et al.
BLOOD CANCER JOURNAL (2020)
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells
Joshua Ghofrani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
What Defines NK Cell Functional Fate: Phenotype or Metabolism?
Sophie M. Poznanski et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cell Metabolism and Tumor Microenvironment
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cell Plasticity in Cancer
Sizhe Liu et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Primary Human NK Cell Gene-Editing Reveals a Critical Role for NKG2A in Cytokine-Induced Memory-like NK Cell Responses
Melissa M. Berrien-Elliott et al.
BLOOD (2019)
Cytokine-Induced Memory-like (ML) NK Cells Persist for > 2 Months Following Adoptive Transfer into Leukemia Patients with a MHC-Compatible Hematopoietic Cell Transplant (HCT)
Jennifer A. Foltz et al.
BLOOD (2019)
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
Valentina Bonanni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host's Response to Pathogens
Mihai G. Netea et al.
CELL HOST & MICROBE (2019)
Acute myeloid leukemia and NK cells: two warriors confront each other
Aroa Baragano Raneros et al.
ONCOIMMUNOLOGY (2019)
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1
Beatrice Casu et al.
CANCERS (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
Precision therapy for acute myeloid leukemia
Xue Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mass cytometry identifies the expansion, persistence, and immune checkpoints of adoptively transferred memory-like NK cells in patients with leukemia
Melissa M. Berrien-Elliott et al.
CANCER RESEARCH (2018)
Epigenetic control of innate and adaptive immune memory
Colleen M. Lau et al.
NATURE IMMUNOLOGY (2018)
Memory formation and long-term maintenance of IL-7R alpha(+) ILC1s via a lymph node-liver axis
Xianwei Wang et al.
NATURE COMMUNICATIONS (2018)
Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
Jens H. W. Pahl et al.
FRONTIERS IN IMMUNOLOGY (2018)
TGFβ Imprinting During Activation Promotes Natural Killer Cell Cytokine Hypersecretion
Jennifer A. Foltz et al.
CANCERS (2018)
KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells
Eva-Maria Ewen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice
Lunmei Tan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
Evan Lusty et al.
MOLECULAR IMMUNOLOGY (2017)
Memory responses of natural killer cells
Clair D. Geary et al.
SEMINARS IN IMMUNOLOGY (2017)
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
Emily K. Curran et al.
TRENDS IN IMMUNOLOGY (2017)
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses
Moritz Rapp et al.
SCIENCE IMMUNOLOGY (2017)
Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses
Julia A. Wagner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Preclinical assessment of PM21-particle expanded natural killer cells for ovarian cancer treatment
Jeremiah Oyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia
Daniela Sandoval-Borrego et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
Antonio Curti et al.
CLINICAL CANCER RESEARCH (2016)
Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
Jeremiah L. Oyer et al.
CYTOTHERAPY (2016)
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L. Mundy-Bosse et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells
Luhua H. Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide
Sharline Madera et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
Sinead E. Keating et al.
JOURNAL OF IMMUNOLOGY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Harnessing NK Cell Memory for Cancer Immunotherapy
Todd A. Fehniger et al.
TRENDS IN IMMUNOLOGY (2016)
TriKEs and BiKEs join CARs on the cancer immunotherapy highway
Szun Szun Tay et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing
Conor J. Kearney et al.
ONCOIMMUNOLOGY (2016)
Metabolic regulation of natural killer cells
David K. Finlay
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
IL-12/15/18-preactivated NKcells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation
Christian M. Hueber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
BNIP3-and BNIP3L-Mediated Mitophagy Promotes the Generation of Natural Killer Cell Memory
Timothy E. O'Sullivan et al.
IMMUNITY (2015)
Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
Molly P. Keppel et al.
JOURNAL OF IMMUNOLOGY (2015)
Human Cytokine-Induced Memory-Like Natural Killer Cells
Melissa M. Berrien-Elliott et al.
JOURNAL OF INNATE IMMUNITY (2015)
Antigen-specific NK cell memory in rhesus macaques
R. Keith Reeves et al.
NATURE IMMUNOLOGY (2015)
Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
Loredana Cifaldi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
A. Baragano Raneros et al.
GENES AND IMMUNITY (2015)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion
Alexander Roelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly et al.
JOURNAL OF IMMUNOLOGY (2014)
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
Uwe Reusch et al.
MABS (2014)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
Isabela Pedroza-Pacheco et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12
Monika Majewska-Szczepanik et al.
IMMUNOLOGY (2013)
Murine NK Cell Intrinsic Cytokine-Induced Memory-like Responses Are Maintained following Homeostatic Proliferation
Molly P. Keppel et al.
JOURNAL OF IMMUNOLOGY (2013)
Human Cytomegalovirus-Induced NKG2Chi CD57hi Natural Killer Cells Are Effectors Dependent on Humoral Antiviral Immunity
Zeguang Wu et al.
JOURNAL OF VIROLOGY (2013)
Natural killer cells: walking three paths down memory lane
Gundula Min-Oo et al.
TRENDS IN IMMUNOLOGY (2013)
The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles
Eue-Soon Jang et al.
BIOMATERIALS (2012)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
Bree Foley et al.
BLOOD (2012)
Cytokine activation induces human memory-like NK cells
Rizwan Romee et al.
BLOOD (2012)
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
Beatriz Sanchez-Correa et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Proinflammatory cytokine signaling required for the generation of natural killer cell memory
Joseph C. Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The Bone Marrow Functions as the Central Site of Proliferation for Long-Lived NK Cells
Mary J. G. van Helden et al.
JOURNAL OF IMMUNOLOGY (2012)
Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
Julia Hilpert et al.
JOURNAL OF IMMUNOLOGY (2012)
Natural killer cell immune escape in acute myeloid leukemia
E. Lion et al.
LEUKEMIA (2012)
Genital HSV-2 Infection Induces Short-Term NK Cell Memory
Mohamed F. Abdul-Careem et al.
PLOS ONE (2012)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
Dawn Holt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
Sandra Lopez-Verges et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Correction: Thy1+Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
Geoffrey O. Gillard et al.
PLoS Pathogens (2011)
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
Celine Berthon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses
Silke Paust et al.
NATURE IMMUNOLOGY (2010)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-12-Dependent Inducible Expression of the CD94/NKG2A Inhibitory Receptor Regulates CD94/NKG2C+ NK Cell Function
Andrea Saez-Borderias et al.
JOURNAL OF IMMUNOLOGY (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
RUNX proteins in transcription factor networks that regulate T-cell lineage choice
Amelie Collins et al.
NATURE REVIEWS IMMUNOLOGY (2009)
TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells
Rossana Trotta et al.
JOURNAL OF IMMUNOLOGY (2008)
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Cunren Liu et al.
BLOOD (2007)
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells
Ye Zheng et al.
NATURE (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors
Casimir de Rham et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells
Jianhua Yu et al.
IMMUNITY (2006)
T cell- and B cell-independent adaptive immunity mediated by natural killer cells
JG O'Leary et al.
NATURE IMMUNOLOGY (2006)
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
M Gumá et al.
BLOOD (2006)
Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias
P Nowbakht et al.
BLOOD (2005)
Imprint of human cytomegalovirus infection on the NK ceH receptor repertoire
M Gumá et al.
BLOOD (2004)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development
I Taniuchi et al.
CELL (2002)
STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation
A Morinobu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
O Mandelboim et al.
NATURE (2001)